TICKERNERD
Menu
CTVACTVABasic Materials · Agricultural Inputs

CTVA Stock Forecast: Corteva, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$84
−0.70% on the day

The 22 Wall Street analysts covering Corteva, Inc. hold a median 12-month price target of $95 — +13.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 58 of 100 as at 11 Sept 2026 — in the upper half.

Market cap
$56.0B
Ticker Nerd rank
58 / 100
Median analyst target
$95
Analysts covering
22
Revenue$4.9B+11.0% y/y
Operating income$1.2B
Net income$723.0M
Free cash flow−$3.0B
Quarterly, 7 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.3%
1M
+10.3%
YTD
+26.0%
1Y
+16.0%
From 52W high
−7.1%
From 52W low
+38.8%
$60
$90
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CTVA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Corteva, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 11 Sept 2026
58 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
98
Quality
71
Momentum
66
Value
60
Issuance
60
Revisions
57
Accruals
51
Growth
47
Size
5

Volatility (98): The share price has been relatively steady.

Growth (47): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (5): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CTVA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CTVA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$60$70$80$90$100$110Oct 25Jan 26Apr 26Jul 26CTVAHigh $103Median $95Low $78

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says22 analysts
14 Buy8 Hold0 Sell
Low $78Median $95High $103

The green dot is the last close — the median target sits +13.2% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 8 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
18 Aug 2026UBSMaintainsNeutral$89 → $85
3 Aug 2026BMO CapitalMaintainsOutperform$95 → $100
3 Aug 2026BMO CapitalMaintainsOutperform—
3 Aug 2026CitigroupMaintainsNeutral$85 → $86
3 Aug 2026CitigroupMaintainsNeutral—
3 Aug 2026JP MorganMaintainsNeutral—
3 Aug 2026JP MorganMaintainsNeutral$77 → $83
3 Aug 2026UBSMaintainsNeutral—
3 Aug 2026UBSMaintainsNeutral$86 → $89
23 July 2026OppenheimerMaintainsOutperform$89 → $95
23 July 2026OppenheimerMaintainsOutperform—
21 July 2026RBC CapitalMaintainsOutperform—
21 July 2026RBC CapitalMaintainsOutperform$97 → $103
20 July 2026B of A SecuritiesMaintainsBuy—
20 July 2026B of A SecuritiesMaintainsBuy$90 → $96
14 July 2026MizuhoMaintainsOutperform—
14 July 2026MizuhoMaintainsOutperform$96 → $97
2 July 2026MizuhoMaintainsOutperform—
11 June 2026BarclaysMaintainsOverweight—
9 June 2026UBSMaintainsNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CTVA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

CTVA vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Corteva, Inc. returned +16.0% against +17.5% for the S&P 500, dividends included.

CTVA vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120130Oct 25Jan 26Apr 26Jul 26CTVAS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CTVA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.8%
Analysts raising
11
Analysts cutting
4
Fundamentals

Corteva, Inc. (CTVA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
50.8×

Cheaper than 14% of US stocks

Price / sales
3.1×

Cheaper than 39% of US stocks

Price / book
2.2×

Cheaper than 42% of US stocks

EV / EBITDA
13.7×

Cheaper than 25% of US stocks

Growth & margins
Revenue growth (YoY)
−1.2%

Higher than 26% of US stocks

Earnings growth (YoY)
−11.6%

Higher than 25% of US stocks

Gross margin
51.6%

Higher than 64% of US stocks

Operating margin
30.1%

Higher than 87% of US stocks

Net margin
5.7%

Higher than 62% of US stocks

Returns & dividend
Return on equity
4.3%

Higher than 52% of US stocks

Return on assets
4.5%

Higher than 74% of US stocks

Dividend yield
0.9%

Higher than 18% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Corteva, Inc. (CTVA) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Corteva, Inc. has a market value of $56.0B and an enterprise value of $58.7B.

  • Revenue in the twelve months to 31 Mar 2026: $17.9B. The latest quarter shrank 1.2% year on year.

  • Net income over the same four quarters: $1.2B, a 6.6% net margin.

  • Diluted earnings per share, trailing twelve months: $1.70.

  • Free cash flow in the twelve months to 31 Mar 2026: $2.0B, after $578.0M of capital spending.

  • Corteva, Inc. spent $1.1B on share buybacks and $176.0M on dividends in the twelve months to 31 Mar 2026.

  • Shares outstanding: 667.2M.

  • Trailing P/E: 50.8×; forward P/E: 20.4× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.86%, paying out 44% of earnings.

  • Corteva, Inc. employs 21,500 people — $832K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

CTVA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelAgricultural Inputs
CompanyMarket capTKN rank
CTVACorteva, Inc.$56.0B
58
NTRNutrien Ltd.$37.5B
88
CFCF Industries Holdings, Inc.$21.0B
87
MOSThe Mosaic Co.$8.0B
20
ICLICL Group Ltd.$7.3B
64
SMGScotts Miracle-Gro Co.$3.3B
77
CRHCRH PLC*$59.4B
35

* Nearest Basic Materials names by size — few agricultural inputs companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Corteva, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CTVA news & analysis

Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination

Business Wire · 10 Sept 2026negative

Baron & Budd announced a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims related to PFAS contamination. The covered entities include several counties, municipalities, and the Lower Cape Fear Water and Sewer Authority.

Why it matters — A Corteva watcher would care because the settlement represents a financial resolution of PFAS-related litigation that could carry cost and liability implications for the company.

Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million

Reuters · 10 Sept 2026neutral

Chemours, DuPont and Corteva reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims linked to Chemours' Fayetteville Works plant and other historical discharges.

Why it matters — This settlement resolves PFAS-related liabilities for Corteva and its legacy chemical business in North Carolina, clarifying a financial matter relevant to CTVA shareholders.

Corteva, Globachem Enter into Definitive Agreement to Form a Joint Venture to Advance Development, Commercialization of New Formulated Crop Protection Solutions

PRNewsWire · 9 Sept 2026positive

Corteva and Globachem N.V. announced a definitive agreement to form a joint venture aimed at advancing the development, scaling, and commercialization of differentiated formulated crop protection solutions in high-growth markets. The partnership is intended to combine both companies' complementary expertise.

Why it matters — A CTVA watcher would care because the joint venture could expand Corteva's crop protection reach and capabilities in high-growth markets.

Vylor Launches Vylor Edge, New Investment Platform for Global Agriculture Innovation

PRNewsWire · 3 Sept 2026neutral

Vylor, the advanced seed and genetics company set to spin off from Corteva on October 1, 2026, announced the launch of Vylor Edge, a new investment platform focused on accelerating development of advanced technologies in global agriculture.

Why it matters — CTVA watchers would care because it signals the direction of the upcoming Vylor spin-off and its focus on next-generation ag-tech investment ahead of the separation.

Vylor Launches a New Era in Corn: Industry-First Yield and Yield Stability Trait, Advanced Insect Control to Deliver Step-Change in Production, Farmer Profitability

PRNewsWire · 1 Sept 2026positive

Ahead of its planned October 1, 2026 separation, Corteva unveiled the corn pipeline for its advanced seed and genetics spin-off, Vylor. The company announced an industry-first yield and yield stability trait and advanced insect control, with a stated goal of $2 billion in incremental revenue by 2035.

Why it matters — This unveiling signals Corteva's strategy to lock in market leadership in corn ahead of the Vylor separation, a key factor for investors tracking the spin-off's value.

FAQ

Frequently asked questions about CTVA stock

What is the CTVA stock price forecast for 2026-2027?

The 22 Wall Street analysts covering Corteva, Inc. have a median 12-month price target of $95, with estimates ranging from $78 to $103. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CTVA stock a buy right now?

Of the 22 analysts covering Corteva, Inc., 14 rate it a Buy, 8 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Corteva, Inc. 58 out of 100 across roughly 4,600 US stocks as at 11 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CTVA?

As at 11 Sept 2026, Corteva, Inc. ranks 58 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (98 of 100).

Will CTVA stock go up?

No one can know that. What the data says: the median 12-month target from 22 analysts implies +13.2% from the last close, and Ticker Nerd's factor model ranks Corteva, Inc. 58 out of 100 as at 11 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CTVA stock forecast for 2030?

No analyst covering Corteva, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CTVA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $78 to $103 over the next 12 months.

How has CTVA stock performed over the past year?

Corteva, Inc. returned +16.0% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Corteva, Inc. do?

Corteva Inc. is a global agricultural science company that develops and supplies seed and crop protection solutions for farmers and agribusinesses.

What is the latest news on CTVA?

The most recent item we track (Business Wire, 10 Sept 2026): "Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination". Baron & Budd announced a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims related to PFAS contamination. The covered entities include several counties, municipalities, and the Lower Cape Fear Water and Sewer Authority.

Company

About Corteva, Inc.

Corteva Inc. is a global agricultural science company that develops and supplies seed and crop protection solutions for farmers and agribusinesses. Its product portfolio includes advanced seed genetics, trait technologies, herbicides, insecticides, fungicides, biologicals, and seed-applied technologies designed to support crop performance, pest control, and plant health. The company serves a wide range of agricultural markets, including field crops such as corn and soybeans, as well as specialty crops and pasture management needs. Corteva Inc. also provides digital agriculture tools that help improve decision-making across planting, protection, and productivity workflows. With operations across major farming regions, the company plays a significant role in the agricultural inputs market by supplying products and services that support modern crop production and farm resilience.

CEO Mr. Charles Victor Magro B.Sc. (Chem), MBA · 21,500 employees · United States · https://www.corteva.com